Insider Selling: Utah Medical Products CEO Sells 1,915 Shares of Stock (UTMD)
Utah Medical Products (NASDAQ:UTMD) CEO Kevin Cornwell unloaded 1,915 shares of Utah Medical Products stock on the open market in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $56.40, for a total value of $108,006.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Utah Medical Products (NASDAQ:UTMD) traded up 1.79% during mid-day trading on Thursday, hitting $55.66. The stock had a trading volume of 3,999 shares. Utah Medical Products has a 1-year low of $32.99 and a 1-year high of $64.84. The stock’s 50-day moving average is $55.54 and its 200-day moving average is $52.02. The company has a market cap of $210.4 million and a price-to-earnings ratio of 20.13.
Utah Medical Products (NASDAQ:UTMD) last posted its quarterly earnings results on Thursday, October 24th. The company reported $0.68 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.69 by $0.01. On average, analysts predict that Utah Medical Products will post $2.74 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Monday, December 30th. Stockholders of record on Monday, December 16th will be given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 1.80%. The ex-dividend date of this dividend is Thursday, December 12th. This is a boost from Utah Medical Products’s previous quarterly dividend of $0.25.
Utah Medical Products, Inc (NASDAQ:UTMD) is in the business of producing medical devices that are, disposable and for hospital use.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.